Oucomes for children with early loss of B-cell aplasia following CAR T according to further therapy (maintenance vs stem cell transplantation). EFS (A) and OS (B) for patients treated with allogeneic SCT (red line) or maintenance therapy (blue line) for early LBCA after CAR T-cell treatment.